Which antioxidant has preclinical studies occurring to evaluate its effectiveness in reducing MTX toxicity for rheumatoid arthritis?
Katturajan R, S V, Rasool M, Evan Prince S. Molecular toxicity of methotrexate in rheumatoid arthritis treatment: A novel perspective and therapeutic implications. Toxicology. 2021 Sep;461:152909.
Submitted by: Dawn Sollee, PharmD, DABAT on behalf of Florida/USVI Poison Information Center – Jacksonville